Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
115.00    -2.50 (-2.13%)
Bid:
113.00
Ask:
115.00
Spread: 2.00 (1.77%)
Market Cap: £90.24m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

16 Jul 2020 07:00

RNS Number : 1439T
Xaar PLC
16 July 2020
 

Xaar plc

 

Trading update 

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology, today announces a trading update for the six months ended 30 June 2020.

 

TRADING

 

The Board is pleased to announce that trading for the six months ending 30 June 2020 has been in line with expectations and good progress has been made implementing our strategy. Revenue for the period is expected to be £23.7m, representing a decline of 7% relative to H1 2019 and in line with H2 2019.

 

The Printhead business continues to perform well as changes in the go to market strategy have seen early successes with several new accounts won and customers re-engaging with the business. The restructuring undertaken in the second half of 2019 has left the business well positioned both to deal with the current economic climate but also to deliver a sustainable and strong business in the longer-term.

 

The Product Print Systems business has been impacted by COVID-19 with annuities and machine sales both below our original plan. Despite that, good progress has been made in embedding the new strategy and driving operational performance with revenue slightly increased relative to the first half of 2019.

 

The 3D business has continued to make good progress. Despite minor delays due to lockdown restrictions, product development and testing is progressing well and investment in the go to market strategy is underway.

 

BALANCE SHEET AND LIQUIDITY

 

The Group retains a strong balance sheet and cash position. Cash and cash equivalents at 30 June 2020 were £23.9m with both the Printhead and Product Print Systems business improving their cash balance relative to 31 December 2019. The 3D business continues to be well positioned to fund its development and go to market needs. The Group maintains a strong cash focus and disciplined cost controls.

 

CURRENT TRADING AND OUTLOOK

 

The Group continues to manage operations in response to the constraints caused by COVID-19 with the priority of safeguarding the health and wellbeing of our employees. Despite these constraints, operations have remained effective and efficient.

 

As a result of the continued uncertainty surrounding economic conditions globally, the Board will not be providing guidance at this time. The short-term order book is healthy, and the business is well placed to withstand the difficult trading environment. The Board remains focused on the medium-term strategy to return the business to profitability and growth and will provide more details on our future plans at the half year results in September.

 

John Mills, Chief Executive Officer, commented:

 

"We are pleased with our performance for the first half which is testament to the new strategy we have in place and all of our staff who have managed the business well during a tough period. It has been particularly pleasing to see success in re-engaging with our core customer base whilst also winning new business.

 

Although short-term uncertainty will remain, the changes we have made enable us to be well positioned for the long-term. The fundamentals remain compelling, the market opportunity remains significant and we are excited about future of the business."

 

 

Enquiries:

 

Xaar plc

Ian Tichias, Chief Finance Officer

& Company Secretary

 

+44 (0) 1223 423 663 

John Mills, Chief Executive Officer

 

 

Tulchan Communications

 

 

 

+44 (0) 207 353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKELFFBDLFBBB
Date   Source Headline
2nd Jan 20182:52 pmRNSTotal Voting Rights
14th Dec 201711:11 amRNSAgreement
1st Dec 20171:55 pmRNSTotal Voting Rights
21st Nov 20178:56 amRNSNOTIFICATION OF MAJOR HOLDINGS
20th Nov 20177:00 amRNSTrading Statement
15th Nov 20179:20 amRNSXaar strengthens 2020 vision with two developments
1st Nov 201710:04 amRNSTotal Voting Rights
2nd Oct 20172:37 pmRNSTotal Voting Rights
8th Sep 201711:34 amRNSDirector/PDMR Shareholding
6th Sep 20172:43 pmRNS2017 Interim Results
6th Sep 20177:00 amRNS2017 Interim Results
1st Sep 201712:21 pmRNSTotal Voting Rights
17th Aug 201711:55 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Aug 20177:00 amRNSDirector change
1st Aug 20172:26 pmRNSTotal Voting Rights
12th Jul 20177:00 amRNSTrading Statement
4th Jul 20177:00 amRNSNotice of Scheduled Trading Statement
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20179:36 amRNSBlock listing Interim Review
1st Jun 201711:33 amRNSTotal Voting Rights
18th May 201711:10 amRNSREPLACEMENT: Grant of Options
18th May 20178:56 amRNSGrant of Options
16th May 20171:24 pmRNSResult of AGM
2nd May 20171:13 pmRNSTotal Voting Rights
2nd May 20177:00 amRNSBoard Appointment
26th Apr 201710:05 amRNSNotice of 2017 AGM
18th Apr 20177:00 amRNSDirector/PDMR Shareholding - SIP Purchase
11th Apr 20179:35 amRNSDirector/PDMR Shareholding
11th Apr 20179:19 amRNSDirector/PDMR Shareholding
6th Apr 20174:19 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
5th Apr 201712:34 pmRNSTotal Voting Rights - Replacement
3rd Apr 20172:08 pmRNSTotal Voting Rights
3rd Apr 20179:43 amRNSWORLD LEADING 3D CENTRE FORMALLY OPENED
29th Mar 20171:11 pmRNSConfirmation of Board Changes
28th Mar 20173:22 pmRNSDirector/PDMR Shareholding
24th Mar 20172:42 pmRNSNotification of Major Interest in Shares
22nd Mar 20177:00 amRNSFinal Results
8th Mar 20173:11 pmRNSNotice of Scheduled Results
1st Mar 20174:38 pmRNSTotal Voting Rights
1st Feb 20175:42 pmRNSTotal Voting Rights
24th Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSXerox partnership agreement
3rd Jan 20174:23 pmRNSBlock listing Six Monthly Return
3rd Jan 20174:20 pmRNSTotal Voting Rights
15th Dec 20167:00 amRNSScheduled Trading Statement
15th Dec 20167:00 amRNSInvestment in 3D Printing
12th Dec 20167:00 amRNSNotice of Scheduled Trading Statement
1st Dec 20161:52 pmRNSTotal Voting Rights
1st Nov 20163:48 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSBoard change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.